Our top pick for
SenesTech, Inc is a specialty chemicals business based in the US. SenesTech shares (SNES) are listed on the NASDAQ and all prices are listed in US Dollars. SenesTech employs 34 staff and has a trailing 12-month revenue of around USD$249,000.
|Latest market close||USD$1.47|
|52-week range||USD$1.32 - USD$13|
|50-day moving average||USD$1.5307|
|200-day moving average||USD$1.7508|
|Wall St. target price||USD$4|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.437|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-07)||-16.95%|
|1 month (2020-12-15)||0.68%|
|3 months (2020-10-15)||-19.23%|
|6 months (2020-07-15)||-26.13%|
|1 year (2020-01-15)||185.33%|
|2 years (2019-01-15)||77.11%|
|3 years (2018-01-13)||N/A|
|5 years (2016-01-13)||N/A|
|Gross profit TTM||USD$42,000|
|Return on assets TTM||-92.91%|
|Return on equity TTM||-208.77%|
|Market capitalisation||USD$6.1 million|
TTM: trailing 12 months
There are currently 74,663 SenesTech shares held short by investors – that's known as SenesTech's "short interest". This figure is 62.7% up from 45,888 last month.
There are a few different ways that this level of interest in shorting SenesTech shares can be evaluated.
SenesTech's "short interest ratio" (SIR) is the quantity of SenesTech shares currently shorted divided by the average quantity of SenesTech shares traded daily (recently around 574330.76923077). SenesTech's SIR currently stands at 0.13. In other words for every 100,000 SenesTech shares traded daily on the market, roughly 130 shares are currently held short.
However SenesTech's short interest can also be evaluated against the total number of SenesTech shares, or, against the total number of tradable SenesTech shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case SenesTech's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 SenesTech shares in existence, roughly 20 shares are currently held short) or 0.0205% of the tradable shares (for every 100,000 tradable SenesTech shares, roughly 21 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against SenesTech.
Find out more about how you can short SenesTech stock.
We're not expecting SenesTech to pay a dividend over the next 12 months.
SenesTech's shares were split on a 1:20 basis on 5 February 2020. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your SenesTech shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for SenesTech shares which in turn could have impacted SenesTech's share price.
Over the last 12 months, SenesTech's shares have ranged in value from as little as $1.32 up to $13. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while SenesTech's is 1.6135. This would suggest that SenesTech's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait that targets reproduction, and limiting fertility in male and female rats for controlling rat populations. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. The company was founded in 2004 and is headquartered in Phoenix, Arizona.
Everything we know about the CDT Environmental Technology Investment Holdings Limited IPO, plus information on how to buy in.
Everything we know about the Viant Technology Inc IPO, plus information on how to buy in.
Steps to owning and managing EVGN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ETL, with 24-hour and historical pricing before you buy.
Steps to owning and managing EQBK, with 24-hour and historical pricing before you buy.
Steps to owning and managing EIGI, with 24-hour and historical pricing before you buy.
Steps to owning and managing ELTK, with 24-hour and historical pricing before you buy.
Steps to owning and managing DNKN, with 24-hour and historical pricing before you buy.
Steps to owning and managing DKL, with 24-hour and historical pricing before you buy.
Steps to owning and managing DMAC, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.